ARBUTUS BIOPHARMA CORP (ABUS)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michael McElhaugh Former Interim President and Chief Executive Officer | 2025 | $109,658 | $0 | $582,330 | $1,855,495 | $0 | $1,030,667 | $3,578,150 |
| 2024 | $642,500 | $0 | $297,120 | $921,463 | $231,750 | $17,250 | $2,110,083 | |
| 2023 | $483,000 | $0 | $242,730 | $733,355 | $144,900 | $16,500 | $1,620,485 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Tuan Nguyen Chief Financial Officer | 2025 | $359,849 | $0 | $0 | $1,879,890 | $159,756 | $17,500 | $2,416,995 |
| 2024 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| David C. Hastings Former Chief Financial Officer | 2025 | $138,613 | $0 | $296,429 | $944,268 | $0 | $839,052 | $2,218,362 |
| 2024 | $502,000 | $0 | $270,000 | $837,524 | $200,800 | $15,522 | $1,825,846 | |
| 2023 | $477,000 | $0 | $229,100 | $692,382 | $143,100 | $15,224 | $1,556,806 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Lindsay Androski President and Chief Executive Officer | 2025 | $437,750 | $0 | $0 | $714,751 | $216,512 | $0 | $1,369,013 |
| 2024 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |